Diagnosing and Managing Parkinson's Disease in Older Adults

Ray Dorsey, MD, MBA
Ann Kriebel-Gasparro, DrNP, MSN, CRNP, FNP-BC,GNP-BC
Marketa Marvanova, PharmD, PhD, BCGP, BCPP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: May 31, 2019 Expiration: May 31, 2020

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Demonstrate increased knowledge and competence in diagnosis and staging of Parkinson’s disease
  • Develop individualized treatment plans that optimally manage symptoms, decrease motor fluctuations in OFF periods, reduce the incidence of dyskinesia, and maximize patient functionality and quality of life.

Information on this Educational Activity


Ray Dorsey, MD, MBA

David M. Levy Professor of Neurology
Director, Center for Health + Technology
University of Rochester
Rochester, New York

Ray Dorsey, MD, MBA, discloses the following conflicts of interest. Research support: AbbVie, Acadia, AMC Health, Biosensics, GlaxoSmithKline, Nuredis Pharmaceuticals, Pfizer, Prana Biotechnology, Raptor Pharmaceuticals, Roche, Teva; Consultant: 23andME, Abbot, AbbVie, American Well, Biogen, Clintrex, DeciBio, Denali Therapeutics, GlaxoSmithKline, Lundbeck, MC10, MedAvante, Mednick Associates, Olson Research Group, Optio, Origent Data Sciences, Inc., Prilenia, Putnam Associates, Sanofi, Shire, Sunovion Pharma, Teva, UCB, Voyager Therapeutics
Marketa Marvanova, PharmD, PhD, BCGP, BCPP

Associate Professor and Chairbr /> Department of Pharmacy Practice
School of Pharmacy/
College of Health Professions
North Dakota State University
Fargo, North Dakota

Marketa Marvanova, PharmD, PhD, BCGP, BCPP, has no conflicts of interest to disclose.
Ann Kriebel-Gasparro, DrNP, MSN, CRNP, FNP-BC,GNP-BC

Walden University Clinical Instructor
MSN NP Program in the School of Nursing
President, Liberty Chapter of GAPNA
Philadelphia, Pennsylvania

Ann Kriebel-Gasparro, DrNP, MSN, CRNP, FNP-BC,GNP-BC, has no conflicts of interest to disclose.


The credit providers require all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Target Audience

Physicians, advanced practice nurses, physician assistants, and consultant or senior care pharmacists who care for older adults.


Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians. 

The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Accreditation Support:
Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277.

Nursing Continuing Education

This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA), the University of Cincinnati, the American Society of Consultant Pharmacists, and MCM Education.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387

Pharmacist Continuing Education

The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity, ACPE UAN 0203-9999-19-035-H01-P is approved for 1.0 contact hour. Participants must view the activity in its entirety, complete the post-test (80% or higher) and evaluation to receive CPE credit. Initial Release Date: May 31, 2019 Expiration Date: May 31, 2020.

ASCP external reviewers: Kristy Daub Falco, PharmD, BCGP, Clinical Pharmacy Specialist, Geriatrics/Hospice & Palliative Care, VA Connecticut Healthcare System

Laura Finn, BCGP, FASCP, Consultant Pharmacist, President - Finn Consultants, Adjunct Associate Professor of Pharmacy Practice, Philadelphia College of Pharmacy/University of the Sciences

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 31, 2019, through May 31, 2020:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 80% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Concise CCO activity on selecting second-generation antipsychotics for treatment augmentation in patients with MDD and managing adverse events

Rakesh Jain, MD, MPH Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 7, 2020 Expired: May 6, 2021

Free slides from CCO and Rakesh Jain, MD, MPH: Expert insights on efficacy, role of antipsychotics in MDD, mitigating and manage adverse events

Rakesh Jain, MD, MPH Released: May 7, 2020

Free slides from CCO and Christoph U. Correll, MD: Expert insights on comorbidities in treatment augmentation for MDD

Christoph U. Correll, MD Released: April 13, 2020

Patient cases on treatment, including efficacy, safety, motor fluctuations, OFF time, and more.

Stuart Isaacson, MD Rajesh Pahwa, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: April 7, 2020 Expired: April 6, 2021
Jointly provided by the University of Cincinnati.

ACCME Accreditation Support:
Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277

Jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA).
Jointly provided by the American Society of Consultant Pharmacists.
Telephone: 703-739-1300 or 800-355-2727
This activity is supported by an educational grant from
Acorda Therapeutics, Inc.
Neurocrine Biosciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?